Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001662579-24-000102

Chief People Officer gave up 1,102 shares (to pay taxes)

  • Chief People Officer acquired 3,750 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Schick Kelly Chief People Officer 2024-11-07 Option exercise +3,750 57,590 D
Schick Kelly Chief People Officer 2024-11-07 Shares withheld for taxes −1,102 $6.04 $6,656 56,488 D
Derivatives
Schick Kelly Chief People Officer 2024-11-07 Option exercise · Performance Restricted Stock Units −3,750 10,500 D
Loading xslF345X05/wk-form4_1731446234.xml…